Can Denosumab Prevent Breast Cancer?

Structure_model_denosumab_OPG_RANKL
Share

From Osteoporosis to Breast Cancer Denosumab, a biologic agent, and bisphosphonates, which are small molecule drugs, reduce fractures that are complications of osteoporosis, including those caused by breast cancer hormone therapies that block estrogen signaling, menopause, or surgically-induced menopause (oophorectomy with or without hysterectomy). Both denosumab and bisphosphonates also reduce the risk of bone metastasis … Read moreCan Denosumab Prevent Breast Cancer?

Share